Clinical Trial

Registry and Biorepository for IBD in Central Texas

Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, non-interventional registry and biorepository for patients with IBD. Longitudinal follow-up data is collected from both patients and their treating gastroenterologist during routine clinical encounters. The biorepository will consist of prospective collection of blood samples, tissue samples, and fecal samples for research purposes, while the participants are undergoing a clinically-indicated procedure (i.e. venipuncture for routine tests, IV catheter placement, and/or endoscopy). Participants may choose to provide any or all of the aforementioned information and/or samples.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2020-11-04.
Status change: Not Yet Recruiting → Recruiting 2021-05-13
Trial Details
NCT Number NCT04617184
Lead Sponsor University of Texas at Austin
Conditions Crohn Disease, Ulcerative Colitis, Inflammatory Bowel Diseases
Enrollment 1,000 participants
Start Date 2021-06-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2021-05-18